AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Mochida receives import approval for Osteomark NTx Serum test.(Brief Article)
2002 SEP 26 - (NewsRx.com & NewsRx.net) -- Ostex International, Inc., (OSTX) announced its Japanese partner, Mochida Pharmaceutical Co., Ltd., has been granted import approval for the Osteomark NTx Serum test in Japan.
Ostex will now begin selling the Osteomark NTx Serum test, in the microtiter format, exclusively to Mochida for distribution in Japan.
Under the terms of the agreement with Mochida, the import approval from the Ministry of Health, Labor and Welfare (MHLW, formally Koseisho) triggers a $250,000 milestone payment from Mochida to Ostex.
Thomas Bologna, chairman, president, and CEO of Ostex stated, "Mochida has done an ...
- Mochida receives import approval for Osteomark NTx Serum test.
- Newspaper article from: Blood Weekly September 26, 2002 700+ words
...Ltd., has been granted import approval for the Osteomark NTx Serum test in Japan. Ostex will now begin selling the Osteomark NTx Serum test, in the microtiter format, exclusively to...
- Japanese Patent Office Allows Two Patent Applications Protecting Ostex'...
- Press release article from: Business Wire May 18, 1998 700+ words
SEATTLEBW HealthWireMay 18, 1998-- Ostex' Japanese Partner Mochida Pharmaceutical Co., Inc. is the Exclusive Manufacturer and Marketer of Osteomark in Japan Ostex International, Inc. (NASDAQ NM:OSTX) today announced that the Japanese Patent Office has allowed two of its patent applications for bone
- Ostex International Signs $750,000 Agreement With Mochida Pharmaceutical Co....
- Press release article from: PR Newswire March 5, 2002 700+ words
...manufacture and sell the Osteomark NTx Serum test, in the microtiter...Ostex developed the Osteomark NTx Serum assay that provides...Japan to include the NTx Serum test. In recent...lead product, the Osteomark NTx test, now available...
- European Patent Office Upholds Ostex International Patent.
- Press release article from: Business Wire February 2, 1999 700+ words
...company's lead product, the Osteomark NTx urine test, incorporates breakthrough...510(k) to the FDA for its Osteomark NTx Serum assay and in December 1998 a 510(k) was submitted for the Osteomark NTx point of care device. Forward...
- Ostex International signs license agreement with Japanese firm.
- Newspaper article from: Biotech Week April 10, 2002 700+ words
...under which Ostex will manufacture and sell the Osteomark NTx Serum test, in the microtiter format, exclusively to...development agreement with Mochida, Ostex developed the Osteomark NTx Serum assay that provides a quantitative measurement of...
- Ostex International Announces Third Quarter 2002 Results.
- Press release article from: PR Newswire October 23, 2002 700+ words
...for the first time, sales of our NTx Serum tests to Japan. Sales of NTx Urine...The Company's lead product, the Osteomark NTx test, now available in multiple test...customer base, market acceptance of the Osteomark NTx tests, changing economic conditions...
- Ostex International Announces Fourth Quarter and 1998 Year Results.
- Press release article from: Business Wire February 17, 1999 700+ words
...base. We are particularly excited about the Osteomark(R) NTx Serum test, as noted in our February 8, 1999 press release. The...collagen-related diseases. The Company's lead product, the Osteomark NTx test, incorporates breakthrough and patented technology in...
- Ostex International Inc. in Full Compliance With Nasdaq National Market Listing...
- Press release article from: Business Wire February 8, 1999 700+ words
...the recent FDA clearance for the company's Osteomark(R) NTx Serum test, our NTx and CTx European Patent No. 0 394 296 being...collagen-related diseases. The company's lead product, the Osteomark NTx test, incorporates breakthrough and patented technology in...